Analyst Recommendations

Piper Sandler analyst issues OUTPERFORM recommendation for LI on March 13, 2026 12:35PM ET. The previous analyst recommendation was Neutral.LI was trading at $17.83 at issue of the...

March 13, 2026   LI -0.05%

Bernstein analyst issues MARKET PERFORM recommendation for LI on March 13, 2026 12:35PM ET. The previous analyst recommendation was Market Perform.LI was trading at $17.83 at issue of...

March 13, 2026   LI -0.05%

H.C. Wainwright analyst issues BUY recommendation for BWAY on March 13, 2026 10:43AM ET. The previous analyst recommendation was Buy.BWAY was trading at $13.74 at issue of the...

March 13, 2026   BWAY -7.30%

Benchmark analyst issues BUY recommendation for VEON on March 13, 2026 11:17AM ET. The previous analyst recommendation was Buy.VEON was trading at $44.31 at issue of the analyst...

March 13, 2026   VEON 1.61%

Morgan Stanley analyst issues OVERWEIGHT recommendation for SE on March 13, 2026 11:15AM ET. The previous analyst recommendation was Overweight.SE was trading at $85.16 at issue of the...

March 13, 2026   SE 0.01%

Bank of America Securities analyst issues BUY recommendation for EH on March 12, 2026 06:04PM ET. The previous analyst recommendation was Buy.EH was trading at $12.11 at issue...

March 12, 2026   EH 5.70%

Bank of America Securities analyst issues BUY recommendation for BIDU on March 12, 2026 07:02PM ET. The previous analyst recommendation was Buy.BIDU was trading at $123.16 at issue...

March 12, 2026   BIDU 0.29%

Morgan Stanley analyst issues OVERWEIGHT recommendation for YMM on March 12, 2026 06:59PM ET. The previous analyst recommendation was Overweight.YMM was trading at $8.985 at issue of the...

March 12, 2026   YMM 0.85%

Barclays analyst issues OVERWEIGHT recommendation for CX on March 12, 2026 04:28PM ET. The previous analyst recommendation was Overweight.CX was trading at $10.36 at issue of the analyst...

March 12, 2026   CX 1.16%

H.C. Wainwright analyst issues BUY recommendation for PHAR on March 12, 2026 03:53PM ET. The previous analyst recommendation was Buy.PHAR was trading at $15.3786 at issue of the...

March 12, 2026   PHAR -0.72%